Overcoming obstacles with LAMA
TRI shares just one of the features of Thalocan’s Lesion Area Mapping Assistant (LAMA) – revolutionizing clinical assessment of HS, among other indications. Learn more at: https://www.thalocan.com/lama/
TRI shares just one of the features of Thalocan’s Lesion Area Mapping Assistant (LAMA) – revolutionizing clinical assessment of HS, among other indications. Learn more at: https://www.thalocan.com/lama/
The fourth in our series of Conversations with Portia Combow and living with HS. Thalocan Research Innovations CEO Eric Zudak and Portia discuss the roadblocks she’s encountered with clinical studies. Watch the full webinar/conversation at www.thalocan.com/webinars/.